Asia-Pacific Stem Cell Market By Mode Of Treatment (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Regenerative Medicine, Musculoskeletal, Eye & Immune System Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion, Sub-Culture), By Type (Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cell, Natural Rosette Cells), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

Asia-Pacific Stem Cell Market By Mode Of Treatment (Autologous & Allogeneic), By Applications (CNS, CVS, GIT, Regenerative Medicine, Musculoskeletal, Eye & Immune System Development), By Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion, Sub-Culture), By Type (Adult Stem Cells, Human Embryonic Cells, Pluripotent Stem Cell, Natural Rosette Cells), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 1087 | Pages: 136 | April 2018 | Region: Asia Pacific


Asia-Pacific Stem Cell Market was worth USD 3310 million in 2018 and estimated to reach USD 5330 million by the end of 2023 with a CAGR of 10%. The allogeneic stem cell therapy is expected to command the largest share of the market in 2016. The market is expected to grow rapidly because of the extensive research and development which is being done. In the field of life sciences, one of the most promising markets at the moment is the global stem cell market and is expected to grow exponentially in the coming years as stem cells allow cost-effective treatment of many illnesses that currently have no or ineffective treatment.

Regenerative medicine is perhaps the most important use of stem cells, and other important areas include oncology, haematology, orthopaedics, cardiology and neurology. Another widely found application is drug discovery and development. Stem cells are kind of a research tool, as their in vitro study would allow scientists to understand in depth about the role of various organs and the development of particular illnesses; stem cells may also possibly allow drug developers to test emerging therapies on diseased cells. Stem cells therapy has shown substantial potential to treat cancer successfully. Cancer stem cells which have been tested on animals have shown satisfactory results. 

Some of the key drivers of Asia-Pacific stem cell market are improved funding from various organizations for research and development for unmet medical needs, growing industry attention on stem cell research, and growing awareness across the world about stem cell therapies. Factors such as improving economic stability, better income, growing medical tourism in emerging countries such as India and China, patients from the U.S. and Europe opting for affordable yet quality treatment in these countries, thriving contract research industry, and high rate of chronic diseases is currently driving the stem cells market in Asia-Pacific region. While on the other hand, ethical issues are involved in the stem cells research and strict regulations to conduct trials on humans are some of the restraining factors. Also factors such as lack of required infrastructure and complications associated with the preservation of stem cell are limiting the growth of the stem cells market.

The stem cell market is segmented based on the treatment mode, cell types, applications, and technology. Treatment mode is segmented into allogeneic and autologous stem cell therapy. The cells type segment contains adult stem cells, induced pluripotent stem cells, human embryonic stem cells, and others. In the global stem cells market, the adult stem cells hold the highest share, while the market share of induced pluripotent stem cells is likely to grow in the next few years. The technology segment is divided into cell acquisition, cell production, cryopreservation and other sub-segments. On the basis of geography, the Asia-Pacific market is analysed under various regions namely India, China, Japan and South Korea. As of now, North America region dominates the global stem cells market. Europe comes next. However, the Asia-Pacific stem cell therapy market is expected to grow the fastest in this forecast period, mainly because of better regulatory support through encouraging government policies and increasing awareness among the public.

Some of the major players in this market are Athersys, StemCells Inc., Cryo Cell International, Geron Corporation, Mesoblast Ltd., Aastrom Biosciences Inc., Celgene Corporation, Invitrogen and Cytori Therapeutics Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By mode of treatment                           

                                5.1.1 Autologous             

                                5.1.2 Allogeneic

                5.2 By application                            

                                5.2.1 CNS            

                                5.2.2 CVS            

                                5.2.3 GIT             

                                5.2.4 Regenerative Medicine     

                                5.2.5 Musculoskeletal   

                                5.2.6 Eye & Immune System Development          

                                5.2.7 Blood Disorders    

                5.3 By technology                           

                                5.3.1 Cell Acquisition     

                                5.3.2 Cell Production     

                                5.3.3 Cryopreservation 

                                5.3.4 Expansion

                                5.3.5 Sub-Culture            

                5.4 By type                        

                                5.4.1 Adult Stem Cells   

                                5.4.2 Human Embryonic Cells     

                                5.4.3 Pluripotent Stem Cell          

                                5.4.4 Natural Rosette Cells          

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction              

                                6.2 China            

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea

                                6.6 Australia      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Athersys                      

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Cryo Cell International                           

                8.4 Geron Corporation                  

                8.5 Mesoblast                  

                8.6 Aastrom Biosciences                               

                8.7 Celgene Corporation                              

                8.8 Invitrogen                   

                8.9 Cytori Therapeutics                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

                                               

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Stem Cells Market By mode of treatment, From 2018-2023 ( USD million )                                                      
  2. Asia-Pacific Autologous Market By Region, From 2018-2023 ( USD million )                                                             
  3. Asia-Pacific Allogeneic Market By Region, From 2018-2023 ( USD million )                                                               
  4. Asia-Pacific Stem Cells Market By Application, From 2018-2023 ( USD million )                                                      
  5. Asia-Pacific CNS Market By Region, From 2018-2023 ( USD million )                                                           
  6. Asia-Pacific CVS Market By Region, From 2018-2023 ( USD million )                                                            
  7. Asia-Pacific GIT Market By Region, From 2018-2023 ( USD million )                                                             
  8. Asia-Pacific Regenerative Medicine Market By Region, From 2018-2023 ( USD million )                                                     
  9. Asia-Pacific Musculoskeletal Market By Region, From 2018-2023 ( USD million )                                                   
  10. Asia-Pacific Eye & Immune System Development Market By Region, From 2018-2023 ( USD million )
  11. Asia-Pacific Blood Disorders Market By Region, From 2018-2023 ( USD million )                                                    
  12. Asia-Pacific Stem Cells Market By Technology, From 2018-2023 ( USD million )                                                      
  13. Asia-Pacific Cell Acquisition Market By Region, From 2018-2023 ( USD million )                                                     
  14. Asia-Pacific Cell Production Market By Region, From 2018-2023 ( USD million )                                                     
  15. Asia-Pacific Cryopreservation Market By Region, From 2018-2023 ( USD million )                                                 
  16. Asia-Pacific Expansion Market By Region, From 2018-2023 ( USD million )                                               
  17. Asia-Pacific Sub-Culture Market By Region, From 2018-2023 ( USD million )                                                            
  18. Asia-Pacific Stem Cells Market By type, From 2018-2023 ( USD million )                                                    
  19. Asia-Pacific Adult Stem Cells Market By Region, From 2018-2023 ( USD million )                                                   
  20. Asia-Pacific Human Embryonic Cells Market By Region, From 2018-2023 ( USD million )                                                    
  21. Asia-Pacific Pluripotent Stem Cell Market By Region, From 2018-2023 ( USD million )                                                         
  22. Asia-Pacific Natural Rosette Cells Market By Region, From 2018-2023 ( USD million )                                                          
  23. Japan Stem Cells Market By mode of treatment, From 2018-2023 ( USD million )                                                 
  24. Japan Stem Cells Market By Application, From 2018-2023 ( USD million )                                                 
  25. Japan Stem Cells Market By Technology, From 2018-2023 ( USD million )                                                 
  26. Japan Stem Cells Market By type, From 2018-2023 ( USD million )                                                               
  27. China Stem Cells Market By mode of treatment, From 2018-2023 ( USD million )                                                  
  28. China Stem Cells Market By Application, From 2018-2023 ( USD million )                                                 
  29. China Stem Cells Market By Technology, From 2018-2023 ( USD million )                                                 
  30. China Stem Cells Market By type, From 2018-2023 ( USD million )                                                               
  31. India Stem Cells Market By mode of treatment, From 2018-2023 ( USD million )                                                   
  32. India Stem Cells Market By Application, From 2018-2023 ( USD million )                                                   
  33. India Stem Cells Market By Technology, From 2018-2023 ( USD million )                                                  
  34. India Stem Cells Market By type, From 2018-2023 ( USD million )                                                
Middle East And Africa Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequen...
Latin America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Asia-pacific Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targ...
Europe Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted G...
North America Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Tar...
Microbiome Sequencing Services Market By Technology (sequencing By Synthesis (SBS), Sequencing By Ligation (SBL), Pyrosequencing, Sanger Sequencing, And Others), By Application (shotgun Sequencing, Targeted Gene Seq...
Middle East And Africa Platelet Rich Plasma Market By Application (Orthopaedics, Cos0metic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Global Ind...
Latin America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Asia-Pacific Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Si...
Europe Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, Size, Sh...
North America Platelet Rich Plasma Market By Application (Orthopaedics, Cosmetic Surgery, Ophthalmic Surgery, Neurosurgery), By Product (Pure, Leukocyte-Rich, Leukocyte-Rich Fibrin), By Region - Industry Analysis, S...
Platelet Rich Plasma Market -Segmented By Product Type, Application, And Region - Global Growth, Trends, And Forecast -2023...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.